North America Ultrasound Transducer Market Segments and Growth by 2027

North America Ultrasound Transducer Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Linear, Convex, Phased Array, Endocavitary, CW Doppler, TEE Probes, Others); Application (Cardiovascular, General Imaging, Musculoskeletal, OB and GYN, Vascular, Other); End User (Hospital, Clinics, Diagnostic Centers, Ambulatory Surgery Centers (ASCs))

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00012991
  • Category : Life Sciences
  • No. of Pages : 168
  • Available Report Formats : pdf-format excel-format
  • Last update date : October 09, 2020
Buy Now
North America Ultrasound Transducer Market Segments and Growth by 2027
Report Date: October 09, 2020   |   Report Code: TIPRE00012991 Email: sales@theinsightpartners.com
Buy Now

2019 Market Size

US$ 1,570.93 Mn

Base year value

2027 Forecast

US$ 2,093.15 Mn

Projected by 2027

CAGR 2020-2027

4.0 %

Growth rate

Addressable Market

US$ 15,053.90 Mn

(2020-2027)

The North America ultrasound transducer market is expected to reach US$ 2,093.15 Mn in 2027 from US$ 1,570.93 Mn in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027.



The growth of the market is driven by the factors such as, growing prevalence of chronic diseases and increase in funds for ultrasound research are expected to augment the growth of the market. However, shortage of medical staff in North America is likely to have negative impact on the growth of the North America Ultrasound Transducer Market in the coming years.

Ultrasound imaging is used in anesthesiology, cardiology, angiology (vascular), gastroenterology/colorectal surgery, hemodynamics, gynecology/obstetrics, otolaryngology, and emergency medicine, among others. It has been widely used for both diagnostic as well as therapeutic procedures. Therefore, there has been increase in ultrasound imaging research activities. Additionally, there are government funds as well as private funds for ultrasound imaging research.

The Society for Academic Emergency Medicine (SAEM) focuses on improving emergency patient care and thus supports the research activities by innovative researchers and experts in emergency medicine. The SAEMF/Academy of Emergency Ultrasound (AEUS) Research Grant will provide up to US $10,000 for an applicant conducting research on point-of-care ultrasound on clinical practice or characterize point-of-care ultrasound learning curves.


Similarly, the Focused Ultrasound Foundation conducts and funds research activities in order to advance new applications of focused ultrasound that will fulfill an unmet clinical need, are cost-effective, and can become a standard of care. In May 2020, the foundation funded “Focused Ultrasound Treatment of Cerebral Cavernous Malformations Project”.   


Thus growing funds for Ultrasound research is likely to drive the market growth in the North American region.

Furthermore, North America is witnessing the growing number of COVID-19 cases, for instance, in the United States the number of cases has been increased to 1,895,507 with 108,79 deaths reported. Additionally, Mexico and Canada cases are also growing. Due to coronavirus spreading, many cities are shutting down causing treatments and doctor’s appointment cancellation. Patients with serious health conditions, such as Cardiovascular, General Imaging, Musculoskeletal, OB and GYN, Vascular needs physical distancing with others, however, delays in such chronic disease treatments is distressing. However, In the situation of covid-19 many companies such as Siemens Healthineers, General Electric Company are taking initiative in the United States, used ultrasound in the treatment of covid19. For instance, Siemens Healthineers, is providing lung ultrasound which is strongly recommended for acute respiratory failure and can be a useful alternative during the COVID-19 outbreak if CT is not readily available. presented with flu-like symptoms and COVID-19 pneumonia. Therefore, it is likely to affect ultrasound transducers market owing to above mention points.


Mexico Ultrasound Transducer Market Revenue and Forecast to 2027 (US$ Mn)

Mexico Ultrasound Transducer Market Revenue and Forecast to 2027 (US$ Mn)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Ultrasound Transducer – Market Segmentation

By Product

  • Linear
  • Convex
  • Phased Array
  • Endocavitary
  • CW Doppler
  • TEE Probes
    • Type
      • 2D TEE Probes
      • 3D TEE Probes
      • 4D TEE Probes
    • Age group
      • Pediatric
      • Adult
  • Others

By Application

  • Cardiovascular
  • General Imaging
  • Musculoskeletal
  • OB and GYN
  • Vascular
  • Other

By End User

  • Hospital
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgery Centers (ASCs)

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • General Electric Company
  • Samsung (Samsung Medison Co Ltd)
  • Hitachi, Ltd. (Hitachi Medical Systems Europe Holding AG)

North America Ultrasound Transducer Report Scope

Report Attribute Details
Market size in 2019 US$ 1,570.93 Million
Market Size by 2027 US$ 2,093.15 Million
CAGR (2020 - 2027) 4.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Linear
  • Convex
  • Phased Array
  • Endocavitary
  • CW Doppler
  • TEE Probes
By Application
  • Cardiovascular
  • General Imaging
  • Musculoskeletal
  • OB and GYN
  • Vascular
By End User
  • Hospital
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgery Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • General Electric Company
  • Samsung (Samsung Medison Co Ltd)
  • Hitachi, Ltd. (Hitachi Medical Systems Europe Holding AG)
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA